OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Abivax SA/  FR0012333284  /

Euronext - Paris
2024-08-30  11:12:16 AM Chg. +0.120 Volume Bid2024-08-30 Ask2024-08-30 High Low
11.560EUR +1.05% 6,188
Turnover: 71,801.820		 11.500Bid Size: 444 11.580Ask Size: 127 11.660 11.540
GlobeNewswire 08-06 Abivax Announces ABTECT Phase 3 Trial Achieves Key Enrollment Milestone
GlobeNewswire 07-15 Abivax Provides Operational and Key Program Update
GlobeNewswire 06-12 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...
GlobeNewswire 06-04 Abivax releases the results of its May 30, 2024 Ordinary and Extraordinary General Meeting
GlobeNewswire 05-08 Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and preclinical...
GlobeNewswire 05-07 Abivax annual ordinary and extraordinary general meeting of May 30, 2024 - Availability of the prepa...
GlobeNewswire 04-05 Abivax publishes financial reports with the French and U.S. securities regulatory agencies
GlobeNewswire 04-02 Abivax reports 2023 financial results and operational update
GlobeNewswire 02-07 Abivax appoints Ana Sharma as Vice President, Global Head of Quality
GlobeNewswire 02-02 Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severel...
GlobeNewswire 01-24 Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obef...
GlobeNewswire 01-22 Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months
GlobeNewswire 01-04 Evexta Bio Announces the Appointment of Paul Gineste, PharmD, as Chief Development Officer
GlobeNewswire 01-04 Abivax 2024 Financial Communication Calendar
GlobeNewswire 2023-12-14 Nasdaq Welcomes 125 IPOs and 26 Exchange Transfers in 2023
GlobeNewswire 2023-11-21 Abivax announces the resumption of its liquidity contract
GlobeNewswire 2023-11-14 Abivax to participate in the Piper Sandler 35th Annual Healthcare Conference
GlobeNewswire 2021-01-12 DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and immunotherap...
TeleTrader 2020-05-25 Germany approves Abivax coronavirus product trial
GlobeNewswire 2019-05-23 Global Infectious Vaccines Partnering Deal Trends, Players and Financials 2019 - Access to Over 250 ...
GlobeNewswire 2019-01-25 Global HIV Competitor Landscape Report 2018: Analysis of Current & Potential Future Product Position...
GlobeNewswire 2018-01-31 LifeSci Advisors Announces 12th Board Appointment Through Its Board Placement Initiative
GlobeNewswire 2018-01-31 LifeSci Advisors Announces 12th Board Appointment Through Its Board Placement Initiative
GlobeNewswire 2017-01-23 DEINOVE strengthens its Board in line with its strategic focus
GlobeNewswire 2016-11-22 ABIVAX to Host Key Opinion Leader Luncheon for Investors Focused on Novel Approaches to HIV Therapy